Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)

PHASE3CompletedINTERVENTIONAL

Enrollment

409

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Pain

Interventions

DRUG

ketoprofen 100 mg

100 mg b.i.d. for 5 days

DRUG

ketoprofen

150 mg b.i.d. for 5 days

Trial Locations (1)

Sanofi-Aventis Administrative Office, Paris